Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Fish and Richardson
Covington
AstraZeneca
Daiichi Sankyo
Baxter
Express Scripts
Queensland Health

Generated: February 18, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,006,924

« Back to Dashboard

Which drugs does patent 10,006,924 protect, and when does it expire?

Patent 10,006,924 protects KORLYM and is included in one NDA.

This patent has five patent family members in five countries.

Summary for Patent: 10,006,924
Title:Method for differentially diagnosing ACTH-dependent cushing's syndrome
Abstract: This invention provides for an improved method for differentially diagnosing ACTH-dependent Cushing's syndrome. Current practice for differentially diagnosing ectopic ACTH syndrome and Cushing's Disease measures relative ACTH concentrations from the inferior petrosal venous sinus compared to fluid obtained from a periphery venous sample. This is performed before and after administration of exogenous corticotropin releasing factor, or after administration of metyrapone. This invention uses glucocorticoid receptor antagonists to induce release of endogenous CRH which stimulates ACTH to increase in patients with ectopic ACTH syndrome but not in those with Cushing's Disease.
Inventor(s): Moraitis; Andreas G. (Menlo Park, CA)
Assignee: Corcept Therapeutics, Inc. (Menlo Park, CA)
Application Number:15/796,443
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 10,006,924

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Corcept Therap KORLYM mifepristone TABLET;ORAL 202107-001 Feb 17, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial TREATING CUSHING'S SYNDROME ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 10,006,924

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2016305092 ➤ Try a Free Trial
Canada 2994422 ➤ Try a Free Trial
European Patent Office 3335043 ➤ Try a Free Trial
South Korea 20180052120 ➤ Try a Free Trial
World Intellectual Property Organization (WIPO) 2017027851 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Mallinckrodt
US Army
QuintilesIMS
UBS
Deloitte
Fish and Richardson
Teva
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.